4342
K. Prabakaran et al. / Tetrahedron Letters 51 (2010) 4340–4343
Table 4
Pyrazolylisoquinolines, 3f–m
Acknowledgements
Sl. No.
Substrate 1, 2 and product 3
Yielda
%
The authors wish to express their gratitude to the Indian Insti-
tute of Science, SAIF, Bangalore and Syngene International Limited
for their support of NMR, LC–MS and IR facilities.
Entry
R
R1
R2
1
2
3
4
5
6
7
8
3f
H
H
CH3
Ph
CH3
Ph
Ph
C2H5
CH3
Ph
80
82
85
76
83
87
85
83
3g
3h
3i
3j
3k
3l
H
H
Cl
Cl
Cl
Cl
CH3
C2H5
CH3
Ph
CH3
C2H5
Supplementary data
Supplementary data associated with this article can be found, in
Ph
C2H5
3m
a
Isolated product yield, characterized by spectral techniques.
References and notes
R1
1. Anthony, O. K.; Nobuyoshi, Y. Topics Organomet. Chem. 2004, 6, 205.
2. Ioannis, N. H.; Didier, S.; Ulrike, N.; Anita, S.; Erhart, B.; Weerts, K.; Martine, C.;
Wim, V. Org. Process Res. Dev. 2009, 13, 596.
3. Antonio de la, H.; Angel, D.; Andres, M. Chem. Soc. Rev. 2005, 34, 164.
4. Xin-Hua, L.; Jing, Z.; An-na, Z.; Bao-An, S.; Hai-Liang, Z.; Shan, B.; Pinaki, B.;
Chun-Xiu, P. Bioorg. Med. Chem. 2009, 17, 1207.
Cl
N
R2
N
N
N
R
Pd(dba)2
5. Véronique, J.; Patrick, Y. AIDS Rev. 1999, 1, 37.
6. Robert, T. H.; Stacey, R. S.; James, F. N.; Jay, B. F.; John, P. D.; Peter, J. S.; Vincent,
J. P. L.; Sophie, L.; Sonal, R.; Isabel, N.; John, A. J.; Steven, S. Bioorg. Med. Chem.
Lett. 2009, 19, 410.
R
7. Johnston, G. A. R. Pharmacol. Ther. 1996, 69, 173.
8. Heike, B.; Julia, W.; Christian, A.; Jorg, A.; Matthias, L. Develop. Comp. Immun.
2006, 30, 597.
9. Tadashi, S.; Kunio, T.; Kazuo, N. Chem. Lett. 1983, 12, 791.
R
Cl
10. Tsugio, K.; Shinjiro, K.; Hiroshi, T. Chem. Lett. 1984, 13, 1351.
11. Qinhua, H.; Richard, C. L. Tetrahedron Lett. 2002, 43, 3557.
12. Khan, F. N.; Jayakumar, R.; Pillai, C. N. J. Mol. Catal. A, Chem. 2003, 195, 139.
13. Khan, F. N.; Jayakumar, R.; Pillai, C. N. Tetrahedron Lett. 2002, 43, 6807.
14. Tajudeen, S. S.; Khan, F. N. Synth. Commun. 2007, 37, 3649.
15. Manivel, P.; Roopan, S. M.; Khan, F. N. J. Chil. Chem. Soc. 2008, 53, 1609.
16. Patil, N. T.; Khan, F. N.; Yamamoto, Y. Tetrahedron Lett. 2004, 45, 8497.
17. Roopan, S. M.; Maiyalagan, T.; Khan, F. N. Can. J. Chem. 2008, 86, 1019.
18. Roopan, S. M.; Khan, F. N. Indian J. Heterocyl. Chem. 2008, 18, 183.
19. Roopan, S. M.; Hathwar, V. R.; Kumar, A. S.; Malathi, N.; Khan, F. N. Acta
Crystallogr., Sect. E 2009, 65, o571.
Pd(dba)2
N
N
Pd(dba)2
R2
N
R
N
R1
20. General procedure for the synthesis of 1,3-disubstituted isoquinolines: A mixture
of the 1-chloroisoquinoline (1 mmol), Pd catalyst (0.05 equiv), BINAP
(0.5 equiv), and sodium carbonate (3 mmol) was stirred in dioxane (5 mL) at
60 °C for 2 min under argon atmosphere. Different heterocyclic amines were
then added, and the mixture was microwave irradiated at 110 °C for 1 h. After
completion of the reaction, the resulting solution was concentrated in vacuo,
and the crude product was subjected to silica-gel column chromatography
using CHCl3–CH3OH (95:5) as eluent to afford the pure product (Table 1). The
compounds were conformed by FT-IR, 1H NMR, 13C NMR and MS techniques.21
21. The analysis data of 3a, 3b, 3f and 3g are given below and for the data of the
3c–e, 3h–m see Supplementary data.
R1
HCl
N
R2
N
H
Scheme 3. Mechanism of the reaction.
pare entries 3 and 6). The addition of chelating ligand racemic-BIN-
AP is significant in modification of yields, moreover, addition of
0.5 equiv for 0.05 equiv Pd catalyst is essential for the reaction
and any excess of BINAP did not modify the yields under our exper-
imental conditions. An investigation of the influence of solvents on
coupling reaction was carried out with a range of solvent systems
and it was observed that dioxane gave near quantitative yield
within 1 h. It is worth to mention the Buchwald coupling reaction
when carried out under conventional method under same opti-
mized condition required 6–7 h however with a low yield 57%.
Subsequently, the reaction of a variety of heterocyclic amines,
2a–e and 1-chloroisoquinoline derivative, 1 were studied under
optimised conditions (Table 1). Similarly under optimised condi-
tions, various pyrazoles were reacted with the 1-chloroisoquino-
line derivative to give the pyrazolylisoquinolines 3f–m (Table 4).
The plausible mechanism for the reaction is depicted below
(Scheme 3).
3-(4-Chlorophenyl)-1-(1H-imidazol-1-yl)isoquinoline (3a): Yellow solid, mp
138.5–138.8 °C, 1H NMR (400 MHz, CDCl3): d 8.49 (br s, 1H), 8.19 (br s, 1H),
8.12–8.09 (d, J = 8.6 Hz, 2H), 8.01–8.05 (m, 2H), 7.83–7.85 (t, J = 7.6 Hz, 1H),
7.51–7.48 (d, J = 8.6 Hz, 2H), 7.48 (br s, 1H), 13C NMR (100 MHz, CDCl3): d
140.0, 135.9, 135.0, 131.6, 129.1, 128.9, 128.0, 127.8, 123.7, 117.2, IR (m
cmÀ1),
3069, 2921, 2852, 2186, 2118, 1662, 1624, 1593, 1567, 1488, 1437, 1400, 1350,
1322, 1290, 1245, 1145, 1109, 1101, 1091, 1034, 1012, 954, 905, 858, 822, 737,
677, 652, 520, 454, LC–MS: m/e 306.2, C18H12ClN3.
3-(4-Chlorophenyl)-1-(1H-1,2,3-triazol-1-yl)isoquinoline (3b): Yellow solid, mp
120–121 °C, 1H NMR (400 MHz, CDCl3): d 8.44–8.42 (d, J = 8.5 Hz, 1H), 8.20 (br
s, 1H), 8.16–8.14 (d, J = 8.4 Hz, 2H), 8.075 (br s, 2H), 8.00–7.98 (d, J = 8.2 Hz,
1H), 7.80–7.76 (t, J = 7.2 Hz, 1H), 7.68–7.64 (t, J = 7.7 Hz, 1H), 7.49–7.47 (d,
J = 8.4 Hz, 2H), 13C NMR (100 MHz, CDCl3): d 148.2, 139.6, 136.6, 136.2, 135.1,
131.2, 129.0, 128.5, 128.3, 127.3, 125.9, 121.4, 117.9.; IR (m
cmÀ1), 3131, 3121,
3058, 2955, 2919, 2851, 1624, 1591, 1569, 1495, 1443, 1404, 1346, 1259, 1146,
1089, 1003, 959, 946, 881, 836, 808, 744, 716, 674, 650, 590, 516, 476, 453, LC–
MS: m/e 307.2, C17H11ClN4.
1-(3,5-Dimethyl-1H-pyrazol-1-yl)-3-phenylisoquinoline (3f): Colorless solid, mp
170 °C, 1H NMR (400 MHz, DMSO-d6) 8.52 (s, 1H), 8.19–8.17 (m, 2H), 8.11–8.06
(m, 2H), 7.83–7.79 (m, 1H), 7.66–7.62 (m, 1H), 7.52–7.49 (m, 2H), 7.44–7.40
(m, 1H), 6.21 (s, 1H), 2.35 (s, 3H, -CH3), 2.24 (s, 3H, -CH3), 13C NMR (100 MHz,
DMSO-d6) 150.07 (–C@N, isoquinoline ring), 149.0 (C@C–C6H5), 148.0 (–N–
N@C–CH3), 141.9 (–C@C–CH3), 139.6, 138.3, 131.6, 129.4, 2 Â 129.4, 2 Â 128.5,
127.8, 126.8, 126.8, 122.9, 117.0, 107.7 (–C@C–CH3), 13.9 (–CH3), 13.55 (–CH3),
3. Conclusion
IR (m
cmÀ1) 3050, 2922, 1623, 1589, 1566, 1488, 1463, 1439, 956, 883, 764, 695,
LC–MS: m/e 300.0; C20H17N3; Mol. Wt.: 299.37; Calculated: C, 80.24; H, 5.72; N,
14.04. Found: C, 79.98; H, 5.30; N, 14.01.
3-Phenyl-1-(3,5-diphenyl-1H-pyrazol-1-yl)isoquinoline (3g): Colorless solid, mp
120 °C, 1H NMR (400 MHz, DMSO-d6): 8.57 (s, 1H), 8.18–8.16 (d, J = 8.3 Hz, 1H),
8.08–8.08 (d, J = 8.4 Hz, 1H), 7.99–7.97 (t, 2H), 7.89–7.85 (t, 1H), 7.80–7.77 (m,
2H), 7.73–7.69 (t, 1H), 7.50–7.46 (m, 2H), 7.40–7.37 (m, 5H), 7.27–7.24 (m, 5H).
In conclusion, we have developed a successful microwave irra-
diated palladium-catalyzed reaction for the synthesis of various
1,3-disubstituted isoquinolines in the presence of BINAP and
sodium carbonate as the base in 1,4-dioxane.